Manorama Industries (541974) Q4 19/20 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 19/20 earnings summary
22 Oct, 2026Executive summary
FY20 revenue from operations rose 83.83% YoY to ₹188.24 crore; PAT increased 22.43% to ₹23.33 crore despite COVID-19 disruption in March.
Core CBE growth, export expansion and commissioning of the Birkoni greenfield plant supported volume-led growth and expanded production capability.
Financial highlights
Revenue from operations ₹188.24 crore vs ₹102.40 crore in FY19, up 83.83% YoY; total income was ₹194.19 crore.
EBITDA ₹49.80 crore, up 55.99% YoY, with 26.45% margin; PBT ₹32.37 crore, up 21.86%.
PAT ₹23.33 crore vs ₹19.06 crore, up 22.43%; EPS ₹20.97 vs ₹20.26.
H2 revenue rose 43.85% YoY and EBITDA 37.65%, while PBT fell 14.05% and PAT fell 21.29%.
Cash margin reached ₹31.00 crore, up 56% YoY.
Outlook and guidance
Management expected optimum production levels and consistent growth in FY21 as the new plant ramped up; no quantified revenue or earnings guidance was stated.
Management remained cautiously optimistic on COVID-19, noting the full-year impact was difficult to assess; cost control and cash conservation were priorities.
Strong order books and international demand supported confidence in healthy top- and bottom-line growth and market-share gains.
Management anticipated increased scope if the permitted 5% CBE use in chocolates was raised; this was an expectation, not confirmed policy.
Latest events from Manorama Industries
- Strong Q2/H1 growth and exports support phased expansion despite margin and cash-flow pressures.541974
Q2 26/27 - Manufacturing growth and capacity investment offset the exit from trading.541974
Q4 18/19 - FY23 growth accelerated as capacity expanded, despite input-cost and execution pressures.541974
Q4 22/23 - Revenue rose 37.8% and PAT 65.6% as expansion targets global specialty-fat demand.541974
Q4 21/22 - Revenue advanced, but pandemic pressure cut profit as capacity expansion continued.541974
Q4 20/21 - Q1 FY27 revenue and profit surged, supported by global expansion, capex, and strong margins.541974
Q1 26/27 - Revenue up 76.1%, EBITDA up 92.5%, and major CapEx and expansion plans approved.541974
Q4 25/26 - Record Q3 FY25 revenue and profit, strong margins, and global expansion with new subsidiaries.541974
Q3 24/25 - H1 FY26 revenue and profit surged YoY, margins remained strong, and FY26 guidance was upgraded.541974
Q2 25/26